EUVIMEDEUVIMED entdecken
Crossref

Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Ran Jin, Kathleen Hurwitz, Shia Kent, Leah Jackman, Nafeesa Dhalwani, Neil Accortt, M. Alan Brookhart, Lisa Head, Nihar Desai, Edward Chia Cheng Lai

Journal of Clinical Lipidology · 2026-06 · 20 (6) · e76-e77

DOI: 10.1016/j.jacl.2026.05.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-06. Verfasst von Ran Jin und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jin, R., Hurwitz, K., Kent, S., Jackman, L., Dhalwani, N., Accortt, N., Brookhart, M. A., Head, L., Desai, N., & Lai, E. C. C. (2026). Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease. Journal of Clinical Lipidology, 20(6), e76-e77. https://doi.org/10.1016/j.jacl.2026.05.112

Vancouver

Jin R, Hurwitz K, Kent S, Jackman L, Dhalwani N, Accortt N, et al. Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease. Journal of Clinical Lipidology. 2026;20(6):e76-e77. doi:10.1016/j.jacl.2026.05.112

BibTeX
@article{Jin2026,
  author = {Jin, Ran and Hurwitz, Kathleen and Kent, Shia and Jackman, Leah and Dhalwani, Nafeesa and Accortt, Neil and Brookhart, M. Alan and Head, Lisa and Desai, Nihar and Lai, Edward Chia Cheng},
  title = {Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {e76--e77},
  doi = {10.1016/j.jacl.2026.05.112}
}
Kostenlos starten →